DIDO 1 [SpacePharma]
The DIDO satellites are 3U CubeSat satellites for micro-gravity rersearch designed by the Israeli / Swiss company SpacePharma.
The satellites contain the mGnify miniaturized end-to-end lab, that can be remote controlled from anywhere. The mGnify unit can perform experiments on bacterial growth, antibiotics resistance, self-assembly, enzymatic reactions, polymerization, nanoparticle synthesis, particle aggregation dynamics, emulsion stability and crystallization.
The first satellite, DIDO 1 was originally to fly on a multi satellite mission on a Falcon-9 v1.2 rocket in 2016. The current plans for this satellite are unknown.
The second mission, DIDO 2 or Chen Jiayong 1, carried experiments from a collaboration between Spacepharma Israel Ltd, CAS IPE, Spacety China Ltd, and the Institute of Mechanics. It was originally manifested on a Dnepr rocket. As the availability of Dnepr had become doubtful, it has now been moved to a bulk CubeSat launch on an Indian PSLV-XL. The launch in February 2017 was successful.
A third mission, DIDO 3, was ordered in 2018 as an improved version.
|Type / Application:||Micro-gravity research|
|Power:||Solar cells, batteries|
|Orbit:||496 km × 508 km, 97.51° (#2)|
|DIDO 1||-||202x||with ?|
|DIDO 2 (Chen Jiayong 1)||2017-008BE||15.02.2017||Sr FLP||PSLV-XL||with Cartosat 2D, INS 1A, INS 1B, Flock-3p 1, ..., 88, Lemur-2 22, ..., 29, BGUSat, PEASSS, Al-Farabi 1, Nayif 1|